Tenecteplase improved functional outcomes without added safety risk in selected basilar artery occlusion stroke treated up to 24 hours after onset in the TRACE-5 trial.
In a groundbreaking achievement, Indian scientists have developed an advanced medical device capable of removing blood clots ...
Zerodha CEO Nithin Kamath recently opened up about his terrifying near-death experience after suffering a stroke in January ...